| Literature DB >> 35365527 |
Ting Chen1,2, Xianbin Ding2, Wenge Tang2, Liling Chen2, Deqiang Mao2, Lingling Song1, Xuemei Lian3.
Abstract
OBJECTIVE: To examine the relationship between self-reported snoring and hyperuricaemia in a large-scale population in Chongqing, China.Entities:
Keywords: epidemiology; other metabolic, e.g. iron, porphyria; preventive medicine; public health
Mesh:
Substances:
Year: 2022 PMID: 35365527 PMCID: PMC8977806 DOI: 10.1136/bmjopen-2021-056143
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Data cleaning flowchart.
Characteristics of participants based on the categories of self-reported snoring
| Characteristics | Self-reported snoring | P value | ||
| No | Occasionally | Frequently | ||
| Number of subjects | 11 469 | 5981 | 4939 | |
|
| ||||
| Age | <0.001 | |||
| <45 | 36.18 | 30.16 | 19.80 | |
| 45–59 | 39.64 | 42.37 | 43.59 | |
| >59 | 24.18 | 27.47 | 36.61 | |
| Male | 35.26 | 53.02 | 66.13 | <0.001 |
| Married or living with partner | 87.75 | 88.13 | 88.01 | 0.742 |
| Education level | <0.001 | |||
| Primary or below | 33.16 | 28.57 | 36.83 | |
| Secondary | 49.94 | 53.10 | 49.20 | |
| College or above | 16.90 | 18.32 | 13.97 | |
| Urban | 27.49 | 33.42 | 25.81 | <0.001 |
| Employment | 63.05 | 62.43 | 59.73 | |
| Income (<60 000 RMB) | 59.51 | 55.12 | 59.91 | <0.001 |
|
| ||||
| Smoking | <0.001 | |||
| Never | 80.99 | 69.27 | 59.71 | |
| Current | 14.61 | 23.61 | 31.00 | |
| Ever | 4.40 | 7.12 | 9.29 | |
| Alcohol drinking | <0.001 | |||
| Never or hardly | 53.00 | 38.40 | 37.84 | |
| Occasionally | 37.56 | 45.23 | 40.27 | |
| Often | 9.44 | 16.37 | 21.89 | |
| Tea drinker | 16.27 | 24.33 | 28.10 | <0.001 |
| Sugar-sweetened beverage drinker | 1.96 | 2.51 | 3.52 | <0.001 |
| Oil intake (g/week) | 56.71±0.30 | 56.66±0.42 | 58.33+0.47 | 0.008 |
| Salt intake (g/week) | 48.36±0.27 | 47.45±0.36 | 51.04±0.42 | <0.001 |
| Energy intake (kcal/week) | 12776.57±39.74 | 13241.66±56.36 | 13838.48±64.34 | <0.001 |
| Red meat intake (g/week) | <0.001 | |||
| ≤210.00 | 27.32 | 25.73 | 23.14 | |
| 210.01–350.00 | 26.06 | 25.10 | 21.83 | |
| 350.01–700.00 | 30.23 | 30.48 | 31.91 | |
| >700.00 | 16.39 | 18.69 | 23.12 | |
| Aquatic/sea food products intake (g/week) | <0.001 | |||
| ≤15.17 | 27.10 | 22.07 | 23.87 | |
| 15.18–93.33 | 25.01 | 25.75 | 23.73 | |
| 93.34–200.00 | 25.38 | 26.25 | 24.13 | |
| >200.00 | 22.51 | 25.93 | 28.26 | |
| Physical activity (MET minutes/week) | 10176.77±63.98 | 9731.86±86.57 | 9777.99±101.00 | <0.001 |
| Nocturnal sleep duration (h/day) | 7.18±0.01 | 7.04±0.02 | 6.97±0.02 | <0.001 |
| Midday nap duration (min/day) | 28.91±0.33 | 31.17±0.45 | 33.43±0.54 | <0.001 |
|
| ||||
| BMI (kg/m2) | <0.001 | |||
| <24 | 55.07 | 39.26 | 24.20 | |
| 24–27.9 | 35.91 | 45.81 | 47.99 | |
| ≥28 | 9.02 | 14.93 | 27.82 | |
| Kidney function | ||||
| CKD1 | 84.33 | 80.45 | 75.40 | <0.001 |
| CKD2 | 14.97 | 18.66 | 23.16 | |
| CKD3 | 0.66 | 0.80 | 1.28 | |
| CKD4 | 0.02 | 0.05 | 0.12 | |
| CKD5 | 0.02 | 0.03 | 0.04 | |
| Dyslipidaemia | 23.99 | 33.46 | 44.26 | <0.001 |
| Diabetes | 7.35 | 10.18 | 15.02 | <0.001 |
| Hypertension | 28.13 | 36.23 | 50.50 | <0.001 |
Continuous data were described as mean±SD, and statistical significance was assessed by the one-way analysis of variance.
Categorical data were summarised as percentages (%), and statistical significance was assessed by χ2 test.
BMI, body mass index; MET, metabolic equivalent.
Prevalence of hyperuricaemia according to snoring frequency in different groups
| Snoring frequency | Age (n (%)) | Gender (n (%)) | Total | |||
| <45 | 45–59 | >59 | Male | Female | ||
| No | 376 (9.06) | 441 (9.70) | 358 (12.91) | 650 (16.07) | 525 (7.07) | 1175 (10.25) |
| Occasionally | 326 (18.07) | 370 (14.60) | 261 (15.89) | 659 (20.78) | 298 (10.60) | 957 (16.00) |
| Frequently | 299 (30.57) | 452 (20.99) | 347 (19.19) | 820 (25.11) | 278 (16.62) | 1098 (22.23) |
| χ2 | 322.34 | 160.32 | 33.23 | 91.72 | 156.38 | 418.14 |
| P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Association between self-reported snoring and hyperuricaemia
| Variables | NO | Occasionally | Frequently | ||
| OR (95% CI) | OR (95% CI) | P value | OR (95% CI) | P value | |
|
| |||||
| <45 | |||||
| Model 1 | 1.00 (reference) | 2.21 (1.89 to 2.60) | <0.001 | 4.42 (3.72 to 5.25) | <0.001 |
| Model 2 | 1.00 (reference) | 1.51 (1.28 to 1.79) | <0.001 | 2.44 (2.03 to 2.94) | <0.001 |
| Model 3 | 1.00 (reference) | 1.49 (1.26 to 1.77) | <0.001 | 2.38 (1.97 to 2.88) | <0.001 |
| Model 4 | 1.00 (reference) | 1.16 (0.96 to 1.39) | 0.13 |
| |
| 45–59 | |||||
| Model 1 | 1.00 (reference) | 1.59 (1.37 to 1.85) | <0.001 | 2.47 (2.14 to 2.85) | <0.001 |
| Model 2 | 1.00 (reference) | 1.33 (1.14 to 1.55) | <0.001 | 1.88 (1.62 to 2.18) | <0.001 |
| Model 3 | 1.00 (reference) | 1.29 (1.11 to 1.50) | 0.00 | 1.83 (1.57 to 2.12) | <0.001 |
| Model 4 | 1.00 (reference) | 1.09 (0.92 to 1.28) | 0.32 |
| |
| >59 | |||||
| Model 1 | 1.00 (reference) | 1.28 (1.07 to 1.52) | 0.01 | 1.60 (1.36 to 1.88) | <0.001 |
| Model 2 | 1.00 (reference) | 1.25 (1.05 to 1.48) | 0.01 | 1.59 (1.35 to 1.87) | <0.001 |
| Model 3 | 1.00 (reference) | 1.22 (1.03 to 1.46) | 0.03 | 1.58 (1.34 to 1.87) | <0.001 |
| Model 4 | 1.00 (reference) | 1.18 (0.98 to 1.42) | 0.09 |
| |
|
| |||||
| Male | |||||
| Model 1 | 1.00 (reference) | 1.37 (1.22 to 1.54) | <0.001 | 1.75 (1.56 to 1.96) | <0.001 |
| Model 2 | 1.00 (reference) | 1.30 (1.15 to 1.47) | <0.001 | 1.79 (1.59 to 2.00) | <0.001 |
| Model 3 | 1.00 (reference) | 1.25 (1.11 to 1.41) | <0.001 | 1.71 (1.52 to 1.93) | <0.001 |
| Model 4 | 1.00 (reference) | 1.08 (0.94 to 1.23) | 0.28 |
| |
| Female | |||||
| Model 1 | 1.00 (reference) | 1.56 (1.34 to 1.81) | <0.001 | 2.62 (2.24 to 3.06) | <0.001 |
| Model 2 | 1.00 (reference) | 1.42 (1.22 to 1.65) | <0.001 | 2.13 (1.81 to 2.50) | <0.001 |
| Model 3 | 1.00 (reference) | 1.43 (1.22 to 1.66) | <0.001 | 2.13 (1.81 to 2.51) | <0.001 |
| Model 4 | 1.00 (reference) |
|
| ||
|
| |||||
| <24 | |||||
| Model 1 | 1.00 (reference) | 1.48 (1.25 to 1.76) | <0.001 | 1.96 (1.61 to 2.40) | <0.001 |
| Model 2 | 1.00 (reference) | 1.22 (1.02 to 1.45) | 0.03 | 1.39 (1.12 to 1.71) | 0.00 |
| Model 3 | 1.00 (reference) | 1.20 (1.00 to 1.43) | 0.05 | 1.36 (1.10 to 1.68) | 0.00 |
| Model 4 | 1.00 (reference) | 1.13 (0.94 to 1.36) | 0.19 | 1.16 (0.93 to 1.45) | 0.19 |
| 24–27.9 | |||||
| Model 1 | 1.00 (reference) | 1.43 (1.25 to 1.64) | <0.001 | 1.84 (1.61 to 2.10) | <0.001 |
| Model 2 | 1.00 (reference) | 1.21 (1.05 to 1.39) | 0.01 | 1.50 (1.30 to 1.73) | <0.001 |
| Model 3 | 1.00 (reference) | 1.19 (1.03 to 1.37) | 0.02 | 1.48 (1.28 to 1.70) | <0.001 |
| Model 4 | 1.00 (reference) | 1.15 (0.99 to 1.33) | 0.06 |
| |
| ≥28 | |||||
| Model 1 | 1.00 (reference) | 1.42 (1.16 to 1.74) | 0.00 | 1.68 (1.40 to 2.02) | <0.001 |
| Model 2 | 1.00 (reference) | 1.30 (1.06 to 1.61) | 0.01 | 1.47 (1.22 to 1.78) | <0.001 |
| Model 3 | 1.00 (reference) | 1.30 (1.05 to 1.61) | 0.02 | 1.47 (1.21 to 1.79) | <0.001 |
| Model 4 | 1.00 (reference) | 1.25 (1.00 to 1.55) | 0.05 |
| |
| Total | |||||
| Model 1 | 1.00 (reference) | 1.67 (1.52 to 1.83) | <0.001 | 2.50 (2.29 to 2.74) | <0.001 |
| Model 2 | 1.00 (reference) | 1.45 (1.32 to 1.59) | <0.001 | 2.03 (1.84 to 2.23) | <0.001 |
| Model 3 | 1.00 (reference) | 1.43 (1.30 to 1.57) | <0.001 | 2.00 (1.81 to 2.20) | <0.001 |
| Model 4 | 1.00 (reference) |
|
| ||
Model 1: unadjusted model.
Model 2: adjusted for gender (when stratification by gender, it was excluded), age (when stratification by age, it was excluded), marital status, education level, residential region, employment status and household yearly income level.
Model 3: additionally adjusted for smoking status, alcohol drinking status, tea drinking status, sugar-sweetened beverage drinking status, oil intake, salt intake, energy intake, red meat intake, aquatic/sea food products intake, physical activity level, nocturnal sleep and midday nap duration.
Model 4: additionally BMI, kidney function, dyslipidaemia, diabetes and hypertension.
Bold values indicate P value <0.05 in Model 4.
BMI, body mass index.